{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:05:01Z","timestamp":1774987501557,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172650"],"award-info":[{"award-number":["82172650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital Health Development and Scientific Research Special Project","award":["2024-1-4021"],"award-info":[{"award-number":["2024-1-4021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10495-026-02313-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:45:33Z","timestamp":1772873133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel triaptosis-related prognostic signature to assess the clinical value in HER2-low breast cancer: evidence from clinical cohorts and experimental validation"],"prefix":"10.1007","volume":"31","author":[{"given":"Jinsong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengwu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"3","key":"2313_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2313_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAT.0b013e328341e0b5","volume":"43","author":"MC Cummings","year":"2011","unstructured":"Cummings MC et al (2011) Molecular classification of breast cancer: is it time to pack up our microscopes? Pathology 43(1):1\u20138","journal-title":"Pathology"},{"issue":"6","key":"2313_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41571-025-01016-y","volume":"22","author":"CJ Robbins","year":"2025","unstructured":"Robbins CJ, Bates KM, Rimm DL (2025) HER2 testing: evolution and update for a companion diagnostic assay. Nat Rev Clin Oncol 22(6):408\u2013423","journal-title":"Nat Rev Clin Oncol"},{"key":"2313_CR4","doi-asserted-by":"publisher","first-page":"175883592311528","DOI":"10.1177\/17588359231152842","volume":"15","author":"E Nicolo","year":"2023","unstructured":"Nicolo E et al (2023) The HER2-low revolution in breast oncology: steps forward and emerging challenges. Ther Adv Med Oncol 15:17588359231152842","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"2313_CR5","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K (2011) Heterogeneity in breast cancer. J Clin Invest 121(10):3786\u20133788","journal-title":"J Clin Invest"},{"issue":"6720","key":"2313_CR6","doi-asserted-by":"publisher","first-page":"eadk9167","DOI":"10.1126\/science.adk9167","volume":"386","author":"MM Swamynathan","year":"2024","unstructured":"Swamynathan MM et al (2024) Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function. Science 386(6720):eadk9167","journal-title":"Science"},{"issue":"1","key":"2313_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12885-025-14095-y","volume":"25","author":"J Liu","year":"2025","unstructured":"Liu J et al (2025) Novel insight of critical genes involved in breast cancer brain metastasis: evidence from a cross-tissue transcriptome association study and validation through external clinical cohorts. BMC Cancer 25(1):707","journal-title":"BMC Cancer"},{"issue":"1","key":"2313_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40001-025-02370-4","volume":"30","author":"J Liu","year":"2025","unstructured":"Liu J et al (2025) Identification and multi-dimensional validation of mitochondrial permeability transition-driven necrosis-related model to assess the prognosis and immunotherapy value in breast cancer. Eur J Med Res 30(1):113","journal-title":"Eur J Med Res"},{"issue":"12","key":"2313_CR9","first-page":"1263","volume":"27","author":"CX Ma","year":"2013","unstructured":"Ma CX, Ellis MJ (2013) The Cancer Genome Atlas: clinical applications for breast cancer. Oncol (Williston Park) 27(12):1263\u20131269","journal-title":"Oncol (Williston Park)"},{"issue":"269","key":"2313_CR10","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1","journal-title":"Sci Signal"},{"issue":"Database issue","key":"2313_CR11","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T et al (2013) NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res 41(Database issue):D991\u2013D995","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2313_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","volume":"131","author":"GP Wagner","year":"2012","unstructured":"Wagner GP, Kin K, Lynch VJ (2012) Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci 131(4):281\u2013285","journal-title":"Theory Biosci"},{"issue":"11","key":"2313_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A et al (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756","journal-title":"Genome Res"},{"issue":"D1","key":"2313_CR14","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013D646","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2313_CR15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26(12):1572\u20131573","journal-title":"Bioinformatics"},{"issue":"1","key":"2313_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"issue":"30","key":"2313_CR17","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32(30):5381\u20135397","journal-title":"Stat Med"},{"issue":"1","key":"2313_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12967-019-1824-4","volume":"17","author":"Q Song","year":"2019","unstructured":"Song Q et al (2019) Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J Transl Med 17(1):70","journal-title":"J Transl Med"},{"key":"2313_CR19","doi-asserted-by":"publisher","first-page":"939956","DOI":"10.3389\/fgene.2022.939956","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Front Genet 13:939956","journal-title":"Front Genet"},{"key":"2313_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"issue":"18","key":"2313_CR21","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M et al (2015) DSigDB: drug signatures database for gene set analysis. Bioinformatics 31(18):3069\u20133071","journal-title":"Bioinformatics"},{"issue":"D1","key":"2313_CR22","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D et al (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49(D1):D605\u2013D612","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2313_CR23","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S et al (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516\u2013D1525","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2313_CR24","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi M et al (2022) AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50(D1):D439\u2013D444","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2313_CR25","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50(W1):W159\u2013W164","journal-title":"Nucleic Acids Res"},{"key":"2313_CR26","doi-asserted-by":"crossref","unstructured":"D\u2019Amico P et al (2021) Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer. Cancers (Basel), 14(1)","DOI":"10.3390\/cancers14010079"},{"key":"2313_CR27","doi-asserted-by":"crossref","unstructured":"Li Y et al (2021) Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med, 13(580)","DOI":"10.1126\/scitranslmed.abc6894"},{"issue":"3","key":"2313_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1078-0432.CCR-20-2007","volume":"27","author":"DM Collins","year":"2021","unstructured":"Collins DM et al (2021) Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer. Clin Cancer Res 27(3):807\u2013818","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2313_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41419-025-07416-3","volume":"16","author":"J Lu","year":"2025","unstructured":"Lu J et al (2025) PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1. Cell Death Dis 16(1):141","journal-title":"Cell Death Dis"},{"issue":"19","key":"2313_CR30","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-23-4054","volume":"84","author":"ME Gonzalez","year":"2024","unstructured":"Gonzalez ME et al (2024) CCN6 Suppresses Metaplastic Breast Carcinoma by Antagonizing Wnt\/beta-Catenin Signaling to Inhibit EZH2-Driven EMT. Cancer Res 84(19):3235\u20133249","journal-title":"Cancer Res"},{"issue":"35","key":"2313_CR31","doi-asserted-by":"publisher","first-page":"e2300403","DOI":"10.1002\/smll.202300403","volume":"19","author":"M Zhou","year":"2023","unstructured":"Zhou M et al (2023) DH5alpha Outer Membrane-Coated Biomimetic Nanocapsules Deliver Drugs to Brain Metastases but not Normal Brain Cells via Targeting GRP94. Small 19(35):e2300403","journal-title":"Small"},{"key":"2313_CR32","doi-asserted-by":"publisher","first-page":"1662004","DOI":"10.3389\/fimmu.2025.1662004","volume":"16","author":"D Fang","year":"2025","unstructured":"Fang D et al (2025) CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+\/HER2- breast cancer. Front Immunol 16:1662004","journal-title":"Front Immunol"},{"issue":"2","key":"2313_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-021-06385-3","volume":"190","author":"R Jiang","year":"2021","unstructured":"Jiang R et al (2021) Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer. Breast Cancer Res Treat 190(2):203\u2013211","journal-title":"Breast Cancer Res Treat"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02313-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:26:06Z","timestamp":1774985166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02313-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02313-2","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that the research has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Review Committee, Cancer Hospital of the Chinese Academy of Medical Sciences and the patient has given informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"89"}}